Birmingham biotech firm's product scores positive results in UAB test

Birmingham biotech firm's product scores positive results in UAB test


A recent trial by researchers at the University of Alabama at Birmingham yielded positive results for a Birmingham-based biotechnology company's product. UAB researchers successfully used Circulogene Theranostics' molecular testing to identify multiple mutations in advanced ovarian cancer patients following chemotherapy and surgery.



from Biotech News